Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREFor decades, healthcare has looked fundamentally the same. When patients need care, they visit healthcare providers (HCPs) in a physician's office, hospital, or ambulatory outpatient clinic. During these face-to-face interactions, HCPs can gather information by listening to what the patient says and what is left unsaid; by visually examining the patient's body and body language; and, by laying hands on the patient, often one of the most important ways to initiate the healing process.
The COVID-19 pandemic upended that model – driving a perception among patients that healthcare facilities had become one of the riskiest places to visit. At the height of stay-at-home orders, face-to-face office visits dropped significantly. In their place was a sharp increase in the use of telemedicine – that is, the delivery of clinical services via telehealth technology and communications infrastructure.
Read full article now - From Today to Telemedicine: 3 Gaps and Risks